GeekWire logo

GeekWire

linkedin.com

GeekWire provides technology news, analysis, and resources for tech professionals, entrepreneurs, and enthusiasts. It covers developments in the technology industry, produces events and podcasts, and offers tools such as job boards and startup rankings to support the tech community. Its mission is to inform and connect people interested in technology and startups.

Facts

HQ
Seattle
Sectors
Online Audio and Video Media
Founded
2011
Employees
26
Registered name
GeekWire LLC Seattle business license
Founders
John Cook, Todd Bishop

Is this your organization? Claim it

Publication

  • Last published Oct 15

Authors & Editors

Seattle Startup Leaders Oppose Washington's SB 6229, HB 2292 Expanding Capital Gains Tax on Small Business Stock

Seattle startup leaders, including Clearly AI CEO Emily Choi-Greene, oppose Washington State's proposed bills SB 6229 and HB 2292 that would expand the capital gains tax to include profits from qualified small business stock, threatening the viability of startups by taxing founders, early employees, and investors on significant gains. Critics warn this could drive founders and investors to build companies outside Washington, undermining the local tech ecosystem.

Washington Proposal SB 6229 Targets Capital Gains on Startup Stock, Sparking Seattle Tech Backlash Ahead of 2026 Tax Implementation

A new Washington state proposal, SB 6229, aims to tax capital gains from qualified small business stock sales despite existing federal exemptions, prompting concerns from Seattle startup leaders about its potential to discourage local company building. Public hearings are scheduled for January 27, 2026, and the tax would apply to gains on or after that date.

Seattle Startup Overland AI Partners with CAL FIRE to Test Autonomous 4-Wheelers for Wildfire Response

Seattle startup Overland AI is partnering with CAL FIRE to test its self-driving 4-wheelers for wildfire resupply and logistics, marking the technology's first use in civilian firefighting applications beyond its military background. Overland AI, founded in 2022, has existing contracts with U.S. defense agencies and recently raised $32 million to expand production capabilities.

Seattle Startup Emerald Battery Labs Raises $1.1M to Scale Sodium-Ion Battery Technology Competing with Chinese Giants CATL and BYD

Seattle-based Emerald Battery Labs raised nearly $1.1 million in a pre-seed round to scale its sodium-ion battery technology, offering a cheaper and safer alternative to lithium-ion batteries. While China leads in sodium-ion battery production through companies like CATL and BYD, U.S. startups are entering the competition amid growing demand for energy storage solutions.

Rad Power Bikes Rider’s DIY Cinderblock Battery Fire Containment Sparks Safety Debate Amid 2023 CPSC Fire Warnings

A Rad Power Bikes rider shared a DIY cinderblock battery containment solution on Reddit to address fire risks from e-bike lithium-ion batteries, sparking community debate and safety discussions. The concerns follow a 2023 U.S. Consumer Product Safety Commission warning about fire hazards related to certain Rad Power Bikes lithium-ion batteries amid the company's financial struggles.

Adaptive Biotechnologies’ Spinout Digital Biotechnologies Raises $15M Series A to Develop Clinical DNA Sequencing Instrument

Digital Biotechnologies, a Seattle-based subsidiary of Adaptive Biotechnologies, has raised up to $15 million in a Series A round to develop a novel clinical DNA sequencing technology. Adaptive will retain nearly half ownership as Digital Biotechnologies aims to create a high-accuracy, rapid, low-cost sequencing instrument for clinical use.

Mitera Biosciences Secures $1.75M to Develop Pregnancy-Inspired Immunotherapies for Autoimmune and Transplant Patients

Mitera Biosciences has emerged from stealth with $1.75 million to develop therapeutics targeting autoimmune diseases and organ transplant rejection, inspired by the immune tolerance mechanisms of pregnancy. The company focuses on a placenta- and thymus-expressed protein to create novel immunotherapies that aim to reduce side effects of current immunosuppressants.

People

See all 5

Online